Phosphate is the third nutrient monitored by TOR in <i>Candida albicans</i> and provides a target for fungal-specific indirect TOR inhibition.

Liu, Ning-Ning; Flanagan, Peter R; Zeng, Jumei; Jani, Niketa M; Cardenas, Maria E; Moran, Gary P; Köhler, Julia R · Proc Natl Acad Sci U S A · 2017

basic_science · Level V

Where this comes from

Abstract

The Target of Rapamycin (TOR) pathway regulates morphogenesis and responses to host cells in the fungal pathogen <i>Candida albicans</i> Eukaryotic Target of Rapamycin complex 1 (TORC1) induces growth and proliferation in response to nitrogen and carbon source availability. Our unbiased genetic approach seeking unknown components of TORC1 signaling in <i>C. albicans</i> revealed that the phosphate transporter Pho84 is required for normal TORC1 activity. We found that mutants in <i>PHO84</i> are hypersensitive to rapamycin and in response to phosphate feeding, generate less phosphorylated ribosomal protein S6 (P-S6) than the WT. The small GTPase Gtr1, a component of the TORC1-activating EGO complex, links Pho84 to TORC1. Mutants in Gtr1 but not in another TORC1-activating GTPase, Rhb1, are defective in the P-S6 response to phosphate. Overexpression of Gtr1 and a constitutively active Gtr1<sup>Q67L</sup> mutant suppresses TORC1-related defects. In <i>Saccharomyces cerevisiae pho84</i> mutants, constitutively active Gtr1 suppresses a TORC1 signaling defect but does not rescue rapamycin hypersensitivity. Hence, connections from phosphate homeostasis (PHO) to TORC1 may differ between <i>C. albicans</i> and <i>S. cerevisiae</i> The converse direction of signaling from TORC1 to the PHO regulon previously observed in <i>S. cerevisiae</i> was genetically shown in <i>C. albicans</i> using conditional <i>TOR1</i> alleles. A small molecule inhibitor of Pho84, a Food and Drug Administration-approved drug, inhibits TORC1 signaling and potentiates the activity of the antifungals amphotericin B and micafungin. Anabolic TORC1-dependent processes require significant amounts of phosphate. Our study shows that phosphate availability is monitored and also controlled by TORC1 and that TORC1 can be indirectly targeted by inhibiting Pho84.

Medical subject headings